跳转至内容
Merck

Adverse reactions of piroxicam.

Drug intelligence & clinical pharmacy (1987-09-01)
D Gerber
摘要

During the approximately five years (1981-86) that piroxicam has been available in South Africa, the Medicines Safety Centre has received 31 reports of adverse reactions associated with this drug. Among these are two reactions not previously recorded in the literature, paresthesia and hair loss. This article records drug events associated with piroxicam worldwide and tabulates those received by the Centre.

材料
货号
品牌
产品描述

USP
吡罗昔康, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
吡罗昔康, ≥98% (TLC)
Sigma-Aldrich
吡罗昔康, meets USP testing specifications
吡罗昔康, European Pharmacopoeia (EP) Reference Standard
吡罗昔康, European Pharmacopoeia (EP) Reference Standard